Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

About Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL is a macrolide antibiotic formulated as an oral suspension, designed primarily for children and individuals who cannot easily swallow tablets or capsules. Each 5mL of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL contains 200 milligrams of erythromycin base, an active compound that works by inhibiting bacterial protein synthesis, thereby stopping the growth of infection-causing bacteria.

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL is effective against a broad range of Gram-positive and some Gram-negative bacteria. It is a trusted option in both outpatient and hospital settings for its proven efficacy, especially when penicillin is not an option due to allergies. Its liquid form makes it easy to administer, especially for children and elderly patients.

Indications of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL is prescribed for the treatment of various infections caused by susceptible bacteria. Indications include:

• Upper and lower respiratory tract infections (such as pharyngitis, tonsillitis, pneumonia, and bronchitis)

• Skin and soft tissue infections (including impetigo and cellulitis)

• Ear infections (such as otitis media)

• Gastrointestinal infections, including pertussis (whooping cough) and Campylobacter enteritis

• Certain sexually transmitted infections like chlamydia in infants and young children

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL may also be used in some cases as a preventive measure, such as for rheumatic fever prophylaxis in penicillin-allergic patients.

Dosage of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

The recommended dosage of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL depends on the age, weight, and medical condition of the patient. General guidelines are as follows:

• Children: The usual pediatric dose is 30 to 50 mg/kg/day, divided into equal doses every 6 to 12 hours, depending on the severity of the infection.

• Infants under 2 months: Dosage should be carefully calculated and prescribed by a healthcare provider.

• Adults and adolescents (who require a liquid formulation): Doses range from 250 to 500 mg every 6 hours, but this depends on the specific infection.

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL should be shaken well before use and measured accurately using a calibrated measuring spoon or dosing cup. It is typically administered before meals on an empty stomach for better absorption, unless directed otherwise by a physician.

Side-effects of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

While generally well-tolerated, Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL may cause side-effects in some individuals. Common side-effects include:

• Nausea and vomiting

• Abdominal pain or cramping

• Diarrhea

• Loss of appetite

Less common but more serious side-effects include:

• Liver dysfunction or cholestatic hepatitis

• Hearing loss (usually reversible, and mostly in high doses or in patients with kidney impairment)

• Allergic reactions such as rash, itching, or anaphylaxis

• Cardiac issues such as QT prolongation or arrhythmias in susceptible individuals

If any side-effects become severe or unusual, seek immediate medical attention.

Contraindications of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

Erythromycin (MONPHEVIN) is contraindicated in the following cases:

• Hypersensitivity to erythromycin or any macrolide antibiotics.

• Concomitant use with medications that may cause serious heart rhythm disturbances, such as:

  • Cisapride

  • Pimozide

  • Ergotamine or dihydroergotamine

• Patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior erythromycin use.

• Known QT prolongation or ventricular arrhythmias (e.g., torsades de pointes).

Use with caution in patients with liver disease, myasthenia gravis, or those taking other drugs that can prolong the QT interval.

Precautions for Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

Before using Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL, patients should inform their healthcare provider about any of the following:

• Known allergy to erythromycin or other macrolide antibiotics

• Liver disease or abnormal liver function

• History of heart rhythm disorders (e.g., QT prolongation)

• Current use of medications that may interact with erythromycin (e.g., statins, certain antihistamines, warfarin, or digoxin)

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL should be used with caution in newborns, as it has been associated with a rare condition called infantile hypertrophic pyloric stenosis.

Pregnant and breastfeeding women should use Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL only if clearly needed and prescribed by a healthcare professional.

Storage of Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL

Erythromycin (MONPHEVIN) 200mg/5mL Suspension 60mL should be stored in a cool, dry place at a temperature not exceeding 25–30°C. Keep the bottle tightly closed and protect it from direct sunlight and moisture. Do not freeze the suspension.